Point-of-care PCR testing for STIs in the ED reduced length of stay and improved antibiotic stewardship compared with central laboratory testing.

GraftAssure™ technology adoption further broadens with 20 global transplant centers engaged by year-end 2025, including first Canadian ...

Indore: Amid the ongoing water contamination crisis in Bhagirathpura locality, which has claimed multiple lives and affected ...

A 2022 study estimates that at-home flu tests have a sensitivity of about 63% if the test is performed within 72 hours of ...

This is shaping up to be yet another severe flu season, fueled by a new influenza variant. Here's how to use home flu tests ...

CoDiagnostics secures its first patent for the Co-Dx PCR platform in Australia, strengthening IP protection as the point-of-care system awaits regulatory clearance.

Co-Diagnostics receives Australian patent covering Co-Dx PCR platform technologies for nucleic acid detection and analysis: Salt Lake City Wednesday, December 31, 2025, 11:00 Hrs ...

The Australian patent represents the first patent granted for the Company's new point-of-care testing platformSALT LAKE CITY, ...

Earlier this week, another case of foot-and-mouth disease (FMD) was identified, this time in Amahlati Local Municipality, in the Amathole District, Eastern Cape. Chief State Veterinarian Dr Ayla ...

Fulgent is set to buy Bako Diagnostics assets and StrataDx for $55.5M, expanding into anatomic pathology and dermatopathology to scale lab services.

The addition of Bako and StrataDx is anticipated to bolster Fulgent’s lab services business with the inclusion of new ...

Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent"), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced that it has ...